Hims & Hers Launches Injectable, Oral Testosterone Treatments

10:14 AM EDT, 10/21/2026 (MT Newswires) -- Hims & Hers Health (HIMS) said Wednesday it launched injectable and oral testosterone replacement therapies for eligible men, expanding its men's health offerings The new options include a compounded twice-weekly subcutaneous injection, a once-weekly generic testosterone cypionate injection administered intramuscularly, and an oral treatment sold as Kyzatrex. Kyzatrex is FDA-approved and has been shown to help up to 96% of men reach normal testosterone levels within 90 days, Hims & Hers said. Price: 29.05, Change: -0.16, Percent Change: -0.55